CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2026-01-05 | Sohn Catherine A. Director | Purchase | +500 | $4.24 | $2K | 1,500 |
| 2025-09-25 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-03-17 | Sohn Catherine A. Director | Purchase | +1,000 | $5.78 | $6K | 1,000 |
| 2025-02-06 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +18,600 | 18,600 | ||
| 2024-09-26 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +34,900 | 34,900 | ||
| 2023-09-28 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-03-23 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +47,000 | 47,000 |
Page 1 of 1 · 8 trades